TRUBION PHARMA (NASDAQ:TRBN)
3.85
0.19 (4.7%)
| TRUBION PHARMA (NASDAQ:TRBN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.04 | 52 Week High | $6.75 | ||
| Open | $4.13 | 52 Week Low | $1.00 | ||
| Day High | $4.13 | P/E | N/A | ||
| Day Low | $3.85 | EPS | $-1.67 | ||
| Volume | 9,850 | ||||
| More TRBN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| WYE | 2 | FACT | 2 |
| ABII | 1 | ATVI | 1 |
| CNSL | 1 | ERII | 1 |
| GXDX | 1 | IPI | 1 |
| LVB | 1 | NGPC | 1 |
| PMT | 1 | SCMP | 1 |
Entities who have mentioned TRBN
- Morgan Stanley | View Related Stories »
- Raymond James | View Related Stories »
- RBC Capital | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Carl Icahn | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- GLG Partners | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
View All Major News StreetInsider.com Major News for TRBN
- Trubion Pharma (TRBN) Posts Q3 Loss of 33c, Beats Street by 10c; Cuts Burn Rate
- Trubion Pharma (TRBN) Reports Q2 Loss of $0.37, Beats by 5c; Guides FY09
View All ReportsStreetInsider.com Reports on TRBN
- Trubion Pharma (TRBN) CEO Peter Thompson Resigns
- Trubion Pharmaceuticals (TRBN) Announces Retirement of Chairman/CEO
- Trubion Pharma (TRBN) Announces Two Presentations of TRU-016 Product at 2009 ASH Meeting
- Trubion Pharma (TRBN) Posts Q3 Loss of 33c, Beats Street by 10c; Cuts Burn Rate
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
View All Press ReleasesCompany Press Releases on TRBN
- Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
- Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
- Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
- Trubion Announces Dates for Third Quarter and Nine Months 2009 Earnings Conference Call
- Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
StreetInsider Reports on TRBN by Category
View All BlogsBlogs on TRBN
- Readers Ask: Sponge Tech, Telanetix, Trubion Pharmaceuticals
- Exiting Facet Biotech on Biogen's Offer
- Summer Ends with Biotech Buying Spree
- Several Promising Deals for Biotech
- Trubion Pharmaceuticals Q2 2008 Earnings Call Transcript
View All FilingsSEC Filings on TRBN
- Form 4 Trubion Pharmaceuticals, For: Nov 16 Filed by: GILLIS STEVEN
- Form 8-K Trubion Pharmaceuticals, For: Nov 14
- Form 10-Q Trubion Pharmaceuticals, For: Sep 30
- Form 8-K Trubion Pharmaceuticals, For: Nov 05
Comments on TRBN
No comments are currently available.
